A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization.
              
            
            
  
    
      
        Palmer GM, Tiran Z, Zhou Z, Capozzi ME, Park W, Coletta C, Pyriochou A, Kliger Y, Levy O, Borukhov I, Dewhirst MW, Rotman G, Penn JS, Papapetropoulos A.
        
      
    
    Palmer GM, et al. Among authors: penn js.
    Br J Pharmacol. 2012 Mar;165(6):1891-1903. doi: 10.1111/j.1476-5381.2011.01677.x.
    Br J Pharmacol. 2012.
  
  
  PMID: 21943108
  Free PMC article.